清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Lithium Protects Against Suicide in Bipolar Disorder, Study Finds

作者
JoAnn Blake
出处
期刊:Psychiatric news [American Psychiatric Association Publishing]
卷期号:52 (21): 1-1 被引量:1
标识
DOI:10.1176/appi.pn.2017.pp8b2
摘要

Back to table of contents Previous article Next article PsychopharmacologyFull AccessLithium Protects Against Suicide in Bipolar Disorder, Study FindsJoAnn BlakeJoAnn BlakeSearch for more papers by this authorPublished Online:18 Aug 2017https://doi.org/10.1176/appi.pn.2017.pp8b2AbstractA large, extensive Swedish study suggests it may be better to prescribe lithium instead of valproate for bipolar patients who may be at risk for suicide.Psychiatrists in the United States ought to consider prescribing lithium over valproate for bipolar patients with suspected suicidal intentions, according to Jie Song, Ph.D., a researcher in the Department of Medical Epidemiology and Biostatistics at the Karolinska Institutet in Stockholm.iStock/vadimguzhva“Although valproate is used more commonly than lithium in the U.S., the limitation of valproate in suicide prevention needs to be recognized,” wrote Song, in an email to Psychiatric News. “Given the accumulated evidence from literature reporting that lithium potentially has distinct benefits in reducing suicidal behavior, this prescribing practice should be considered more often,” she wrote.Song is the lead author of a Swedish study published in AJP in Advance in June that found about 12 percent of attempted or completed suicides could have been avoided if the individuals in this population had been continuously taking lithium during the study period and entire follow-up. The study also demonstrated that valproate “probably has no effect on suicidal behavior.” Researchers relied on Swedish population-based registers to follow 51,535 individuals with bipolar disorder over an eight-year period (2005-2013). During this period, 10,648 suicide-related events occurred in 4,643 individuals (9 percent). The researchers compared periods when patients were taking either lithium or valproate with periods they were not taking either medication.After excluding participants without suicide-related events or varying covariates during follow-up, 4,405 participants were eligible for the within-individual analysis. These patients had 10,403 suicide-related events, were more often prescribed other drugs, and had more comorbid psychiatric conditions. The suicide-related incidence rate decreased by 14 percent during the time these individuals were receiving lithium compared with periods not receiving lithium. The rate of suicide-related events did not decrease when individuals received valproate.Patients with bipolar disorder are known to have a high risk of suicidal behavior compared with the general population and patients with other psychiatric disorders. Lithium is considered the first-line treatment for bipolar disorder and some previous studies have suggested it confers an anti-suicidal effect, as well. “Lithium has multiple clinical effects, including its mood stabilizing action to prevent manic and depressive episode recurrence, treat acute mania, and reduce suicide risk in patients with bipolar disorder,” according to Song. Although both drugs treat mood disorders, valproate is one of the antiepileptic medications that the Food and Drug Administration requires to include a warning: this class of medications increases the risks of suicidal thoughts or behavior.Several studies support lithium’s protective effects against suicide. A study published in BMC Psychiatry in 2014 found no significant differences in associations with suicide death between lithium and valproate among U.S. Veterans Health Administration patients over the first year of treatment.“Yes, this study seems to diverge from our findings, however, the two studies have different designs and outcomes,” Song explained. “They [VA] used propensity score matching to control for potential measured confounding, while we compared an individual to himself or herself … Their study focused on fatal suicides and the follow-up was only for one year. We followed more than 50,000 individuals for over eight years and focused on suicide-related behavior, where the overwhelming majority are non-fatal suicide attempts. Therefore, our findings are not directly comparable.”The VA study also found a significant increased risk of suicide death after discontinuation or modification of lithium treatment, compared to valproate, for 180 days following the treatment change. Although the Swedish study did not directly compare the difference in rate of suicide-related events between lithium and valproate discontinuation, it also observed an increased rate of suicidal behavior, within 30 days of lithium discontinuation. “Taken together, both studies highlight the positive benefits for lithium against suicidal behavior and the need for close monitoring after discontinuation,” according to Song.Clinicians may hesitate to prescribe lithium to patients at high risk of suicide due to its potential for lethal toxicity in case of overdose, she suggested, and instead may choose valproate because it takes effect more quickly, and is used when patients require rapid mood stabilization. The study was financed with grants from the Swedish Research Council, the Swedish Council for Working Life and Social Research, and the China Scholarship Council. ■Back to Psychopharmacology Newsletter Table of Contents ISSUES NewArchived

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
飞飞的应助被武雨寒采纳,获得10
7秒前
美好雁卉完成签到,获得积分10
17秒前
包容的映之完成签到,获得积分10
24秒前
彩色的芷容完成签到 ,获得积分10
24秒前
谦让康完成签到 ,获得积分10
25秒前
朱洪帆完成签到,获得积分20
38秒前
靓丽的伟祺完成签到,获得积分10
50秒前
从容的凡旋完成签到,获得积分10
52秒前
Jun的应助被朱洪帆采纳,获得10
53秒前
无私的碧玉完成签到,获得积分10
57秒前
果酱完成签到,获得积分10
57秒前
万能图书馆的应助被无限幻枫采纳,获得10
58秒前
1分钟前
Maestro_S的应助被朱洪帆采纳,获得10
1分钟前
1分钟前
KalEl发布了新的文献求助10
1分钟前
Zhangym完成签到 ,获得积分10
1分钟前
安静的傲松完成签到,获得积分10
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
欢喜映阳完成签到,获得积分10
1分钟前
开心恶天完成签到,获得积分10
1分钟前
zjh123完成签到,获得积分10
1分钟前
lily完成签到 ,获得积分10
1分钟前
1分钟前
xuxu213完成签到,获得积分20
1分钟前
1分钟前
无限幻枫发布了新的文献求助10
1分钟前
顺利的三德完成签到,获得积分10
1分钟前
华无剑的应助被xuxu213采纳,获得10
1分钟前
和谐的小懒虫完成签到,获得积分10
1分钟前
李思雨完成签到 ,获得积分10
1分钟前
苗条的之桃完成签到,获得积分10
2分钟前
无辜的凝安完成签到,获得积分10
2分钟前
李成恩完成签到 ,获得积分10
2分钟前
Bill02完成签到 ,获得积分10
2分钟前
外向的香岚完成签到,获得积分10
2分钟前
Xuezhuoxin完成签到,获得积分10
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159011
求助须知:如何正确求助?哪些是违规求助? 9554538
关于积分的说明 21719449
捐赠科研通 7748505
什么是DOI,文献DOI怎么找? 3427122
关于科研通互助平台的介绍 2552015
邀请新用户注册赠送积分活动 2471370